SecBot SecBot
SECBOTREPLAY Home › Report › TEVA

TEVA · GC sells 26,260 shares

TEVA PHARMACEUTICAL INDUSTRIES LTD · 144 filed Nov 4, 2026 at 16:00 ET

At the news

NEUTRALIMPACT 2/10

144 filed Nov 4, 2026 at 16:00 ET

Dov Bergwerk, Teva's Senior VP, General Counsel and Corporate Secretary, filed a Form 144 notice to sell 26,260 ordinary shares with an approximate market value of $1.1 million. The sale is tied to a stock option exercise and sale transaction, executed on the filing date at an indicative price of $41.72 per share. Relative to Teva's $47.4B market cap, the sale is small and routine for an executive exercising options.

  • Insider: Dov Bergwerk, Senior VP General Counsel Corporate Secretary
  • Shares to be sold: 26,260 ordinary shares
  • Approximate value: $1,095,567.20
  • Indicative price: $41.72 per share

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access